当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Gopal Dixit
Making good progress in global wellness and illness prevention and management, particularly for cancer, depends on adopting Ayurveda into our present health care research programmes. Ayurveda encourages the body's intrinsic healing systems to properly function for resilience, health, and immunity. Ayurveda also offers access to a wealth of botanical items with a broad range of pharmacoactive elements and millennia of clinical expertise for health benefits. So far, there is a lack of research that provides evidence for its efficacy and potential. This two-part review is given from the viewpoint of an Ayurvedic practitioner and biomedical scientist with western training. It seeks to encourage further study into ayurvedic herbal substances, protocols, and modalities by teaching research scientist peers about the prospects and barriers involved. Will focus on Ayurveda botanical remedies for cancer and highlight research on specific herbal ingredients. To direct the creation of research projects to validate the safety and efficacy of these medicines, research gaps and opportunities will be identified. It's important to note that using Ayurveda methods in conjunction with allopathic cancer treatments is designed to prevent the illness and restore strength and immunity after treatment, not to substitute treatments.